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Summary
The cellular basis of the in vitro and in vivo T cell responses to Staphylococcus enterotoxin B
(SEB) has been investigated. The proliferation and cytotoxicity of V#8.1,2+,CD4+ and CD8+
T cells were observed in in vitro response to SEB. In primary cytotoxicity assays, CD4+ T cells
from control spleens were more active than their CD8+ counterparts, however, in cells derived
from SEB-primed mice, CD8+ T cells were dominant in SEB-specific cytotoxicity. In vivo
priming with SEB abrogated the response of V$8.1,2+,CD4+ T cells despite the fact that these
cells exist in significant number. This SEB-specific anergy occurred only in V08.1,2+,CD4+ T
cells but not in CD8 ' T cells. These findings indicate that the requirement for the induction
of antigen-specific anergy is different between CD4' and CD8+ T cells in post-thymic tolerance,
and the existence of coanergic signals for the induction of T cell anergy is suggested.
Staphylococcal enterotoxins (SEs)t provoke dramatic T cell
responses (1-3) . These are extremely potent polyclonal
mitogens stimulating a large proportion ofboth murine and
humanT cells. Minor lymphocyte stimulating (Mls) antigens
have a similar nature to SEs (4-6), but the primary structure
of the Mls antigen is not known, as neither the gene nor
its product are yet isolated. These antigens are labeled "su-
perantigen." Recent evidence has demonstrated that these an-
tigens are recognized by T cells expressing particular TCR
Vo gene families in the context ofclass II MHC (Ia) antigen
(7-11), and this was further supported by reports showing
the affinity of SEs to la antigen (12, 13). These antigens are
reported to cause the intrathymic negative selection of reac-
tive cells and result in major effects on the TCR repertoire
in both CD4+ and CD8' T cells (10, 14-19). It was also
shown that post-thymic tolerance to foreign Mls antigen is
achieved by clonal anergy of CD4+ T cells (20). Although
superantigens have these strong effects on the formation of
the repertoire in both CD4+ and CD8+ T cells, it is not
clear whether CD8+ T cells are responsive to these antigens
or under similar control in the induction of post-thymic toler-
ance. Here we demonstrate that both V08.1,2+,CD4+ and
CD8+ T cells in vitro respond to Staphylococcus entero-
toxin B (SEB), whereas in vivo injection ofSEB causes anergy
only in CD4+ but not in CD8+ T cells. These findings in-
dicate that the requirement for the induction ofantigen-specific
anergy is different between CD4+ and CD8+ T cells in
1 Abbreviations used in this paper. Mls, minor lymphocyte stimulating; RT,
room temperature; SE, Staphylococcal enterotoxin.
post-thymic tolerance. It is suggested that antigen recogni-
tion by TCR alone is not sufficient and that supplemental
signals, termed here "Coanergic" signals, are necessary to in-
duce anergy.
Materials and Methods
Mice.
￿
BALB/c byJ mice (4-6 wk old) were obtained from The
Jackson Laboratory (Bar Harbor, ME).
mAbs andMitogens.
￿
B cell hybridoma lines producing antibodies
directed against murine CD4 (GK1.5), CD8 (3.155) were purchased
from American Type Culture Collection (Rockville, MD). VQ8.1,2
idiotype-specific mAb KJ16-133- (21) and V,68.1,2,3 idiotype-
specific mAb F23.1- (22) producing hybridoma lines were provided
by Drs. P. Marrack,J. Kappler (NationalJewish Center for Immu-
nology and Respiratory Medicine, Denver, CO), and M.J. Bevan
(Research Institute of Scripps Clinic, LaJolla, CA). PE-anti-CD4 an-
tibody and PE-avidin were purchased from Becton Dickinson &
Co. (Mountain View, CA). SEA was purchased from Toxin Tech-
nologies, Inc. (Madison, WI). SEB was purchased from Sigma
Chemical Co. (St. Louis, MO) . Con A was purchased from
Boehringer Mannheim Biochemicals (Indianapolis, IN).
CellPreparation.
￿
Spleen cells were treated with biotinated anti-
C134 (GK1.5) or anti-CD8 (3.155) (both were purified from the
supernatant of B cell hybridomas by protein A-Sepharose [Phar-
macia Fine Chemicals, Uppsala, Sweden]). Cells were washed and
mixed with streptavidin magnetic beads (Dynabeads M280; Dynal
A.S., Oslo, Norway) at 10.0 P.1/105 cells for 30 min at room tem-
perature (RT). The magnetically coated cell were isolated by a mag-
netic field generated by MACS, (Miltenyi Biotec GmbH., Meitz-
feld, FRG). Purification for positively coated cells was performed
twice, resulting in >90% purity for the phenotype selected.
CD4- spleen cells, CD8 - spleen cells, or CD4,CD8 double-
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Flow Microfluorometry.
￿
Spleen single cell suspensions ofunprimed
BALB/c mice were treated with Tris-buffered 0.16M ammonium
chloride to lyse the RBC. These cells were cultured for 72 h in
RPMI 1640 medium supplemented with 10% FCS and 5 x 10-5
M 2-ME in a 24-well culture plate at a concentration 2 x 106/ml
per well in the presence-of 10.0 hg/ml SEB or 5.0 hg/ml of Con
A at 37°C. Those cultured or fresh spleen cells were washed and
then incubated with KJ16-133 or F23 .1 culture supernatant at
106/ml for 30 min . These cells were washed three times and
treated with fluorescein (green) goat anti-rat or mouse Ig reagent .
The cells were then treated with PE (red) anti-CD4 antibody or
biotinated anti-CD8 for 30 min . To determine CD8 expression,
cells were washed and further incubated with PE-avidin for an-
other 30 min . Cells were washed followed by two-color (red and
green) fluorescence analysis by Epics-C fluorocytometry (Coulter
Electronics Inc., Hialeah, FL) . All incubations during cell staining
were done on ice.
Proliferation Assay.
￿
Spleen cells were stimulated in vitro with
SEA, -B, or Con A in 96-multiwell tissue culture plates at 105
cells/100,ul or a reciprocal number (2-2-22 x 104 ) of cells in each
well. After 40 h of culture, cells were pulsed with 1 PCi/well of
['H]thymidine (Amersham International, Amersham, UK). Cells
were collected 8 h later by glass fiber filter mats . Radioactivity was
determined in a liquid scintillation beta counter.
11,2 Production Assay.
￿
Single cell spleen suspensions of SEB-
primed or control BALB/c mice were stimulated with SEB (10.0
Wg/ml) in 24-well plastic culture dishes at 2 x 106/ml per well .
Supernatants were collected after 48 h and were tested for the growth
promotion of the IL2-dependent cell line CTLL-1 . To do this,
CTLL-i cells were cultured in 96-well U-bottomed culture plates
at 5 x 104 cells/well in 200 1A1 of medium containing varied con-
centrations ofsamples. After 24 h, cells were pulsed with 1 p.Ci/well
of [ 3H]thymidine for 16 li . Cells were collected onto glass fiber
filter mats by a microsample harvester (Skatron, Inc., Sterling, VA) .
Radioactivity was determined in a liquid scintillation beta counter.
Data indicated are arithmetic means of triplicate samples .
Cytotoxicity Assay.
￿
"Cr (Amersham International)-labeled mu-
rineB lymphoma cells, A20-2J (23) (H-2d, Ia+) (10 4 ), are cultured
with varied number of effector cells (spleen cells) in the presence
of 10 Ntg/ml of SEB in 96-well U-bottomed tissue culture plates
(final volume 200 /.l/well) . 100 P,1 of the 16-h culture supernatant
was assayed for radioactivity by a gamma counter. We performed
a 16-h assay to compare CD4+ T cell cytotoxicity (which is op-
timum after 10 h ; data not shown) and CD8+ T cell cytotoxicity
(which has a faster time course and shows significant cytotoxicity
after 2 h ; data not shown) . Maximum release of "Cr was mea-
sured by incubating targets in 1 M HCI . Spontaneous release of
"Cr from A20-2J cells was consistently -20% after 16 h in cul-
ture . The percentage of specific lysis was calculated as 100x [(ex-
perimental - spontaneous release)/(maximum - spontaneous
release)] .
Results
In Vitro Primary Proliferative Response of Spleen T Cells to
SEB. We compared the relative responsiveness of CD4+
and CD8 + T cells against SEB. Unfractionated spleen cells
were stimulated in vitro withSEB at a concentration of 10.0
hg/ml, and with 5.0,ug/ml ofT cell mitogen, ConA (Table
1) . Two-color fluorescence analysis showed that SEB stimu-
lation dramatically increased the proportion of both CD4+
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and CD8+ T cells expressing Va8.1,2, whereas Con A did
not change the proportion of these T cells compared with
unstimulated fresh spleen cells. The V08.1,2+ cells increased
more than twofold among CD4+ T cells, while V08.1,2+,
CD8+ cells had a lower, but still significant increase. Thus,
it was demonstrated that V(38.1,2+ cells are selectively ex-
panded in both the CD4+ and CD8+ T cell population,by
SEB stimulation .
Proliferative Response ofSEBprimed Spleen Cells.
￿
Wenow
had the unique opportunity to perform a comparative study
o£ the specific immunoresponse ofCD4+ and CD8+ T cells
by a single antigen . Therefore, we further examined the sec-
ondary in vitro response using spleen cells of BALB/c mice
primed with SEB 7 d before the experiment . The size of the
spleen was usually larger in the SEB-primed mice than con-
trol mice and contained two- to threefold more cells than
control spleens, but the ratio of Thy-1 + cells and surface Ig-
positive cells was unchanged (data not shown) . Single cell
suspensions from the spleens of these mice were stimulated
in vitro with SEB to examine the functional capacity in
proliferative response in comparison with that ofPBS-injected
control mice (Fig. 1) . Spleen cells of control mice showed
a strong response at >3 x 104 cpm at 10.0 Ag/ml SEB in
a [ 3H]thymidine incorporation assay (Fig. 1 a) . The spleen
cells derived from SEB-primed mice, however, showed re-
duced levels of proliferation at <104 cpm . Reduction of
proliferation was dependent on the priming dose ofSEB, and
>80% ofthe response was suppressed in 50.014g SEB-primed
mice . The suppressed proliferation ofSEB-primed spleen cells
was further studied by the cell dose titration experiment (Fig.
1 b) . The results indicated a poor proliferation of50 Ftg SEB-
primed spleen cells in response to SEB stimulation, and the
proliferative efficacy was -25% compared with the control
cells . These SEB-unresponsive cells and control cells, how-
ever, showed comparative responses in a proliferation assay
to SEA that stimulates V,61, -3, -11, and -12 TCR+ cells
(24) (Fig . 1 c), indicating that the functional unresponsive-
ness occurred in a SEB-specific manner .
11,2 Production of SEB-primed Spleen Cells .
￿
The results
presented in Fig. 2 showed unresponsiveness in 11,2 produc-
tion of SEB-primed spleen cells . In this experiment, IL -2 in
10.0 leg/ml SEB-stimulated spleen supernatant was quanti-
tated by testing growth-promoting activity on the indicator
cell line, CTLL1 . In SEB-primed mice, the production of
IL-2 in response to in vitro SEB stimulation was suppressed
in a primed dose-dependent fashion. The IL2 production was
already reduced at 1.0 Ag per injection, and [3H)thymidine
uptake was -30% of the control . The entire IL2 produc-
tion was almost abrogated at 50.0 Ag of injection .
Proliferative Unresponsiveness ofCD4+ T Cells in SEBprimed
Spleen . Spleen cells from 50.0 Ecg SEB-primed mice were
further studied by purifying CD4+ T cells and CD8+ T
cells to determine ifboth populations were equally unrespon-
sive to SEB (Fig . 3) . In control mice, both CD4+ and CD8+
T cells responded to SEB (10.0 Fig/ml) in the presence of
CD4- , CD8- spleen cells as the source of la+ cells. The re-
sponse of CD4+ T cells was significantly reduced when cells
purified from SEB-primed mice were used . However, CD8 +Table 1.
￿
In Vitro Primary Prolferative Response of V68.1,2*,CD4* and CD8* Spleen T Cells to SEB
" Proportion of V08.1,2+ cells among CD4+ T cells.
t Proportion of Vj38.1,2+ cells among CD8+ T cells .
T cells from these mice proliferated in response to SEB to
a level comparable with that seen in nonprimed control cells.
Proportional Study of V08+ T Cells in SEBprimed Spleen.
Previous studies have shown that the response of murine T
cells to SEB is specific for the expression of V03- or V#8-
bearing TCR on the responding cell (10). BALB/c is a strain
that has nondetectable levels of V03+ T cells in the pe-
riphery because the Mls allotype is "2'" (8). Therefore, VS8+
T cells represent the only SEB-reactive T cells in this mouse
strain. We therefore examined whether the reduction in
proliferative response was due to the deletion or anergy of
V#8+ T cells. As shown in Table 2, the proportion of
V#8 .1,2+ cells was -20% in CD4+ T cells and -30% in
m
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CD8+ T cells in control mice. The proportion ofV08.1,2+
T cells decreased to -15% in CD4+ T cells in SEB-primed
mice, while the effect of SEB injection on the proportion
of Vf8.1,2+ cells was minimal in CD8+ T cells (but slightly
decreased at a SEB dose of 50.0 lAg). The study of F23.1+
cells (detects all V(38.1+, VQ8.2+, and V08.3+ cells) also
showed similar results in 50 Etg SEB-primed mice. These results
show that V68+ T cells remain in SEB-primed mice, and
thus, CD4+ T cells seem to be in anergy.
Cytotoxic Response ofSEBprimed Spleen Cells to SER
￿
In
another set of experiments, we examined the cytotoxicity of
spleen cells primed with SEB 7 d prior (Fig. 4). The spleen
cells from control mice showed cytotoxicity against an la+
0
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U
c
g
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H
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Figure 1.
￿
Suppression ofSEB-specific proliferative response ofSEB-primed spleen cells to SEB. BALB/c byJ micewere givenone intravenous injection
(by tail vein) of 1.0, 10.0, and 50.0 ug of SEB in 0.2 ml PBS. 1 wk later, spleen cells were in vitro stimulated with 10.0 and 50.0 )Ag/ml of SEB
(a). In the second experiment, reciprocal numbers of 1-wk 50 FAg SEB-primed spleen cells were stimulated with SEB at a concentration of 10.0 ug/ml
(b). Reciprocal numbers of 1-wk 50 lug SEB-primed spleen cells were stimulated with SEB or SEA at a concentration of 10.0 jug/ml (c). Data are
indicated as the arithmeticmean of triplicate samples. SD was normally <10%. Data shown is representative of three experiments. (-) SEB not added;
(+) 10.0 jug/ml SEB added. (SEA) 10 Ftg/ml SEA added.
Phenotype of T cells
Fresh
(n
spleen
= 4)
Percent of positive cells
SEB (10.0 jug/ml)
(n = 3)
Con A (5 .0 Ag/ml)
(n = 3)
CD4* 28 .4 ± 2.1 44.2 ± 2.6 45.9 ± 2.3
CD8 * 10.6 ± 1 .6 46.6 ± 5.9 35.9 ± 7.3
KJ16*, CD4* 6 .0 ± 0.9 23.6 ± 0.2 12.3 ± 0.4
KJ16*, CD8* 3 .0 ± 0.6 19.3 ± 1.9 8.5 ± 0.3
KJ16*, CD4*/CD4+* 19 .9 ± 1 .7 56.7 ± 2.2 26.8 ± 1.3
KJ16*, CD8*/CD8+t 27.6 ± 2.0 42.6 ± 10.4 24.7 ± 4.9
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Unresponsiveness of 11,2 production in SEB-primed spleen.
Single cell spleen suspensions ofSEB-primed or controlmice were stimu-
lated with SEB (10.0 lAg/ml). Supernatants were collected after 48 h and
were tested forgrowth promotionof theI162-dependent cell line CTLIA.
Data are indicated as arithmetic means of triplicate samples.
B cell lymphoma (A20-2J) when 10.0 wg/ml ofSEB was added
to the culture. The observed cytotoxicity was cell dose de-
pendent, and rose to >40% at an E/T ratio of 80 (Fig. 4
a). Cytotoxicity from SEB-primed spleen cells was as high
as the control group and was SEB dose dependent. The CD
phenotypes of these SEB-specific cytotoxic T cells, in both
control and SEB-primed spleen, were determined by cyto-
toxic assays on T cells positively selected for CD4 or CD8
expression. Also, the negative fraction obtained from the se-
lection of CD4+ or CD8+ T cells was tested for SEB-specific
killing (shown in Fig. 4, b and c). In control mice, cytotox-
CD4'
￿
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' The cells expressing V08.1,2+ TCRs .
t The cells expressing V08.1,2,3+ TCRs.
icity was dominantly demonstrated by the CD4+ and the
CD8- cell fractions. The profile of cytotoxic effector T cell
phenotype was inverted in 50.0 Ftg SEB-primedmice, where
the CD8+ and the CD4- cell fractions are dominantly cyto-
toxic. Inhibition studies by anti-CD4 mAb blocked the cy-
totoxicity of the control spleen cells, but the cytotoxicity of
SEB-primed spleen cells was not inhibited. In contrast, anti-
CD8 antibody was not effective in inhibition of cytotoxicity
in either case (data not shown).
7.0
® SEB not added' Table 2. Proportional Study of V,Q8' T Cells in CD4' and
SEB 1 .0vg CD8' T Cells of SEB-primed Mice
SEB 10.Okg
6.0 IIIII SEB 50.ONg Percent
control
Reagents expressing
f
a 5.0 II
primed T cells Origin V08 U
c 0
4.0 PBS KJ16+,' CD4+ CD4+ 20.3 ± 1.6
U F23.1 +,t CD4+ CD4+ 31 .0 ± 1.2
3.0 d c KJ16+, CD8+ CD8+ 28.5 ± 1.3
E
2.0 F23.1+, CD8+ CD8+ 36.6 ± 0.6
i 17
SEB (1 .0 Wg) KJ16+, CD4+ CD4+ 16.3 ± 0.7
1 .0 KJ16+, CD8' CD8+ 27.5 ± 0.8
1110 SEB (10.0 jig) KJ16+, CD4+ CD4' 14.5 ± 1.3
50.0 25.0 12.5 KJ16+, CD8' CD8+ 25.3 ± 5.9
Concentration of Supernatant (oro)
SEB (50.0 Ftg) KJ16+, CD4+ CD4+ 14.2 ± 2.8
L
L
Figure 3. Proliferative unresponsiveness of CD4+ T
cells in SEB-primed spleen. BALB/c byJmice were given
one intravenous injection of 50.0 kg of SEB in 0.2 ml
PBS. 1 wk later, theseparated CD4' and CD8+ spleen
Tcells were mixed (1:1) with theCD4-,CD8- fraction
C° Ilk o ° s~, o ° s F of spleen cells to examine theSEB-specific proliferation.
or '°~i ~r, e °i or "or o,. Data from two separate experiments are presented. (')
Im o" ~w .lea .~eo"
10.0 ug/ml SEB; (t),M pre-injected; (S) SEB 50.0 wg
S pre4njected; (-) SEB not added; (+) 10.0 14g/ml SEB
Exp. 2 Exp.1 Exp. 2 added.U
X
0 v
0
60,
60
" SEB CDs-
￿
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(b), and CD4 - or CD8- fractions
(c) were cultured with 104 s1Cr-
labeledA20-2J and 10.0 jig/ml SEB
at varied effector (spleen cells)/
target (A20-2J) ratios. (c) Specific
lysiswas calculated by the same for-
mula, except that the nonspecific re-
lease from the coculture of effector
and target cells in the absence of
SEB for each IQ /T ratio was used
o
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or CD8 - spleen cells. Presented
data are the means of triplicate wells. SD was normally <10%. Data shown represent threeseparate experiments that consistently gave similar results.
In a, SEB 1, 10, and 50 fcg, indicates the dose of SEB-primed 7 d previous to the experiment.
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Cytotoxic response of
SEB-primed spleen cells to SEB.
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In the studies cited above, we have observed the in vitro
proliferation and cytotoxicity of CD4+ and CD8+ T cells
in response to SEB. In vivo priming with SEB abrogates the
response of V08+,CD4+ T cells despite the fact that these
cells exist in significant number. This supports the previous
observation of anergy occurring in V06+,CD4+ T cells in
Mls-1b mice immunized with Mls-1'-expressing cells re-
ported by Rammensee et al. (20). We also determined that
IIT2 production was suppressed in SEB-primed spleen cells,
which further supports SEB-specific anergy, since it parallels
the results of Rammensee. However, in contrast to Mls-specific
anergy and our in vitro results, we consistently observed a
decreased proportion of V08+, CD4+ T cells in vivo. This
occurred in lymph nodes as well as in spleen (data not shown).
This observation may reflect an in vivo regulatory mecha-
nism to prevent the expansion of particular Va+ T cells by
an idiotypic network. Detailed studies of this reduction of
V08+ T cells in SEB-primed spleen and lymph nodes are
in progress (Kawabe, Y and A. Ochi, manuscript submitted
for publication).
In primary cytotoxicity assays, CD4+ T cells from con-
trol spleens were-more active than their CD8+ counterparts,
but in cells derived from SEB-primed mice, CD8+ T cells
were dominant in cytotoxicity. This may reflect the need of
CD8+ cytotoxic T cells for "help" from CD4+ T cells to
mature functionally (25). It is an intriguing question whether
20-
these functionally mature CD8+ T cells have any connec-
tion with the SEB-induced suppressor T cells that have been
previously reported (2, 26). While no significant suppressor
activity has been observed from these cells with regard to
SEB-specific primary proliferation, the effect may be B cell
specific.
The major question on how CD4+ T cells can be induced
to anergy while CD8+ T cells remain active in vivo remains
to be answered. The observation that CD4+ T cells recog-
nize SEB and la in association with the CD4 molecule (27,
28) may indicate that the induction of anergy requires the
recognition of the antigen-MHC complex by the TCR and
the interaction ofsupporting elements such as CD4 and CD8.
These molecules may indeed mediate "coanergic" signals since
it has been reported that they are capable oftransducing both
positive and negative signals (29-31). Therefore, since CD8+
T cells fail to generate these putative coanergic signals, due
to the lack of the CD4-Ia interaction, this may then explain
the observed tolerance to anergy of CD8+ T cells.
In summary, an experimental system using a soluble, well-
characterized TCR VO-specific antigen that stimulates both
CD4+ and CD8+ T cells in vitro will provide us with an
unique opportunity to elucidate the mechanism of positive
and negative regulation ofT cell response in the post-thymic
environment.
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